Skip to main content
. 2024 Jan 9;16:15–22. doi: 10.2147/BCTT.S442707

Figure 1.

Figure 1

Comparisons of serum triiodothyronine (T3) (A), thyroxine (T4) (B), free triiodothyronine (FT3) (C), free thyroxine (FT4) (D) and thyroid-stimulating hormone (TSH) (E) among healthy controls (n = 90), only primary breast cancer (BC, n = 97) and patients with both primary breast cancer and primary thyroid cancer (BC-TC, n = 97). Data were shown with box plot. ns indicates no statistical significance. ***p < 0.001.